Valuation : PuraPharm Corporation Limited

Market Cap 14Cr 1.77Cr 1.53Cr 1.45Cr 1.31Cr 2.46Cr 169.46Cr 2.47Cr 17Cr 6.61Cr 86Cr 6.66Cr 6.52Cr 272.42Cr P/E 2024
-6.13x
P/E 2025 -4.22x
Enterprise Value 45Cr 5.79Cr 4.99Cr 4.73Cr 4.28Cr 8.04Cr 553.47Cr 8.08Cr 56Cr 22Cr 281.58Cr 22Cr 21Cr 889.76Cr EV / Sales 2024
1.42x
EV / Sales 2025 1.5x
Free-Float
34.74%
Yield 2024 *
-
Yield 2025 -
1 week-3.70%
Current month-5.45%
1 month-7.14%
3 months-13.33%
6 months-21.21%
Current year-26.76%
1 week 0.24
Extreme 0.24
0.27
1 month 0.24
Extreme 0.24
0.29
Current year 0.24
Extreme 0.24
0.38
1 year 0.24
Extreme 0.24
0.46
3 years 0.24
Extreme 0.24
1.26
5 years 0.24
Extreme 0.24
2
10 years 0.24
Extreme 0.24
4.39
Manager TitleAgeSince
Chief Executive Officer 65 05/05/1998
Director of Finance/CFO 38 01/01/2024
Investor Relations Contact - -
Director TitleAgeSince
Chairman 65 05/05/1998
Director/Board Member 60 02/12/2011
Director/Board Member 72 12/06/2015
Date Insider Type Main position Quantity % Market Cap. Importance
27/07/22 Other

Chief Executive Officer

30,000 0.0076%
27/07/22 Other 30,000 0.0076%
03/05/22 Other

Chief Executive Officer

77,500 0.0196%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%-3.70%-42.22%-74.00% 1.77Cr
0.00%-0.73%-15.19%-4.85% 1.34TCr
-1.27%-1.93%-33.50%-57.21% 484.31Cr
-0.61%-3.64%-6.30%-5.58% 438.56Cr
-1.49%-3.37%-12.35%-30.86% 383.86Cr
-2.78%-2.86%-4.36%-2.32% 350.32Cr
-1.37%-4.03%-25.10%+3.51% 346.99Cr
-0.85%-4.50%-13.67%+4.55% 314.75Cr
-1.30%-2.63%-23.93%-16.27% 230.2Cr
-2.13%-3.01%-30.95%-17.00% 166.9Cr
Average -1.18%-2.95%-20.76%-20.00% 405.76Cr
Weighted average by Cap. -0.94%-2.28%-17.10%-13.16%

Financials

2024 2025
Net sales 38Cr 4.87Cr 4.2Cr 3.97Cr 3.6Cr 6.76Cr 465.43Cr 6.79Cr 47Cr 18Cr 236.79Cr 18Cr 18Cr 748.23Cr 34Cr 4.29Cr 3.69Cr 3.5Cr 3.17Cr 5.95Cr 409.43Cr 5.98Cr 42Cr 16Cr 208.3Cr 16Cr 16Cr 658.2Cr
Net income -3.54Cr -45.19L -38.93L -36.86L -33.41L -62.69L -43Cr -63L -4.38Cr -1.68Cr -22Cr -1.7Cr -1.66Cr -69Cr -3.52Cr -44.91L -38.7L -36.64L -33.21L -62.3L -43Cr -62.62L -4.35Cr -1.67Cr -22Cr -1.69Cr -1.65Cr -69Cr
Net Debt 33Cr 4.17Cr 3.59Cr 3.4Cr 3.08Cr 5.78Cr 398.16Cr 5.81Cr 40Cr 16Cr 202.56Cr 16Cr 15Cr 640.08Cr 32Cr 4.02Cr 3.46Cr 3.28Cr 2.97Cr 5.58Cr 384.01Cr 5.6Cr 39Cr 15Cr 195.37Cr 15Cr 15Cr 617.34Cr
Logo PuraPharm Corporation Limited
PuraPharm Corporation Ltd is an investment holding company principally engaged in the concentrated Chinese medicine granule (CCMG) businesses. The Company operates through five business segments. The China CCMG segment is mainly engaged in the production and sales of CCMG products in China. The Hong Kong CCMG segment is mainly engaged in the sales of CCMG products, excluding the sales through self-operated clinics in Hong Kong. The Chinese Healthcare Products segment is mainly engaged in the production and sales of healthcare products in Hong Kong and China. The Clinics segment is mainly engaged in the provision of Chinese medical diagnostic services and sales of CCMG products through self-operated clinics. The Plantation segment is mainly engaged in the plantation and trading of raw Chinese herbs, and the manufacture and sale of traditional Chinese medicine (TCM) decoction pieces.
Employees
460
Date Price Change Volume
11/26/11 HK$0.2600 0.00% 0
10/26/10 HK$0.2600 0.00% 1,60,000
09/26/09 HK$0.2600 0.00% 1,33,000
08/26/08 HK$0.2600 0.00% 10,500
07/26/07 HK$0.2600 -3.70% 28,000

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 1498 Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!